Posted by Two Blokes
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food
Source: Two Blokes Trading
Posted by Two Blokes
I'm downgrading BRSP to a hold due to lackluster earnings, limited growth potential, and continued pressure fr
Source: Two Blokes Trading
Posted by Two Blokes
The central bank's preferred indicators are above 3%, while other gauges have climbed a slower pace.
Source: Two Blokes Trading
Posted by Two Blokes
I upgrade PEG to a strong buy due to explosive data center demand and a de-risked LIPA renewal, ensuring multi
Source: Two Blokes Trading
Posted by Two Blokes
CNBC's Steve Liesman, Morgan Stanley's Jim Caron, JPMorgan's David Kelly and RBC's Frances Donald join 'Power
Source: Two Blokes Trading
Posted by Two Blokes
Nike is delaying the launch of its highly anticipated NikeSKIMS activewear line, according to a person familia
Source: Two Blokes Trading
Posted by Two Blokes
The rate projections give investors and analysts a false sense of precision. Some Fed officials are tired of t
Source: Two Blokes Trading
Posted by Two Blokes
A generation ago, the federal budget was briefly in surplus. Now, it appears headed for a record stretch of pe
Source: Two Blokes Trading
Posted by Two Blokes
Zoox CEO Aicha Evans discusses the robotaxi firm's growth plans from its new manufacturing facility in the San
Source: Two Blokes Trading
Posted by Two Blokes
The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company
Source: Two Blokes Trading
Posted by Two Blokes
Texas Instruments said the $60 billion investment will create 60,000 jobs and called it the "largest investmen
Source: Two Blokes Trading
Posted by Two Blokes
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financi
Source: Two Blokes Trading